Expression and regulation of mRNA for distinct isoforms of cAMP-specific PDE-4 in mitogen-stimulated and leukemic human lymphocytes

Cell Biochem Biophys. 1998;28(2-3):135-60. doi: 10.1007/BF02737809.

Abstract

We reported previously that the gene for PDE-1B1 is induced in isolated human peripheral blood lymphocytes (HPBL) following mitogenic stimulation (Jiang, X., Li, J., Paskind, M., and Epstein, P.M. [1996] Proc. Natl. Acad. Sci. USA 93, 11,236-11,241). Using reverse transcription-polymerase chain reaction (RT-PCR), we investigated possible changes in the expression of the four genes for cAMP-specific phosphodiesterase (PDE-4A-D) in HPBL under the same conditions. Isolated, quiescent HPBL express mRNA for PDE-4B as the principal transcript. Following mitogenic stimulation with phytohemagglutinin (PHA), mRNA for PDE-4A and PDE-4D are clearly induced. HPBL appear not to express PDE-4C under resting or stimulated conditions. The PHA induced increase in PDE-1B1, PDE-4A, and PDE-4D mRNA is mimicked by incubation of HPBL with dibutyryl cAMP (dBcAMP) and 1-methyl-3-isobutylxanthine (IBMX). The B-lymphoblastoid cell line, RPMI 8392, and the T-leukemic cell line, Molt 4, express PDE-4A mRNA as the most abundant transcript, but incubation with dBcAMP and IBMX induces an increase in the expression of mRNA for PDE-4B in both of these cell lines, and in PDE-4D3 in the RPMI 8392 cell line. These studies demonstrate that expression of mRNA for PDE-1B1 and some of the subtypes of PDE-4 are induced in HPBL following mitogenic stimulation, possibly secondarily to elevation of cAMP induced by the mitogen. As already indicated for PDE-1B1, some of these subtypes of PDE-4 might also provide additional therapeutic targets for treatment of immunoproliferative disorders and immune dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • 3',5'-Cyclic-AMP Phosphodiesterases / genetics*
  • B-Lymphocytes
  • Bucladesine / pharmacology
  • Cyclic AMP / physiology
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • Gene Expression Regulation, Enzymologic / immunology*
  • Humans
  • Isoenzymes / genetics*
  • Leukemia, T-Cell
  • Lymphocyte Activation
  • Lymphocytes / enzymology*
  • Mitogens / pharmacology
  • Phosphodiesterase Inhibitors / pharmacology
  • Phytohemagglutinins / pharmacology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • RNA, Messenger / analysis*
  • T-Lymphocytes
  • Tumor Cells, Cultured

Substances

  • Isoenzymes
  • Mitogens
  • Phosphodiesterase Inhibitors
  • Phytohemagglutinins
  • RNA, Messenger
  • Bucladesine
  • Cyclic AMP
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • 1-Methyl-3-isobutylxanthine